Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $55.0000 (-15.38%) ($55.0000 - $65.0000) on Wed. Feb. 20, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 20.41% (three month average) | RSI | 49 | Latest Price | $55.0000(-15.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -5.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -10.205% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -10.205% (StdDev 20.41%) | Hourly BBV | 0 () | Intraday Trend | -15.4% | | | |
|
Resistance Level | $62.28 | 5 Day Moving Average | $66.15(-16.86%) | 10 Day Moving Average | $65.66(-16.24%) | 20 Day Moving Average | $62.28(-11.69%) | To recent high | -40.5% | To recent low | 323.1% | Market Cap | $1.083b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |